ReviewHerzschrittmachertherapie & Elektrophysiologie2026
[Late complications after atrial fibrillation ablation : Diagnosis and management].
Review in Herzschrittmachertherapie & Elektrophysiologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Delayed complications may occur up to weeks after atrial fibrillation (AF) ablation and are usually a consequence of initial injury during ablation and ongoing processes progressing to severe symptomatic but late-onset events. A structured clinical follow-up of patients to appraise for late complications is therefore imperative for all centers performing AF ablations. Late complications should also be reported when testing new ablation technologies. Red flag symptoms like fever, neurological events, and syncope but also delayed onset thoracic pain, dyspnea, exercise intolerance or gastrointestinal symptoms within the first months after AF ablation should trigger standardized diagnostic testing to evaluate for complications like esophageal injury/esophagoatrial fistula, gastroparesis, pulmonary vein stenosis (can become symptomatic even later), diaphragmatic paralysis, or late pericarditis/pericardial effusion. Whereas severe late complications are rare, the remote onset of associated symptoms warrants a high degree of awareness of all medical disciplines involved in the follow-up and also on the patient side to assure appropriate management without further delay. Indicative symptoms, incidences, and standardized management workflows for late complications like esophagoatrial fistula, gastroparesis, pulmonary vein stenosis, phrenic nerve injury/diaphragmatic palsy, and late pericarditis/pericardial effusion are discussed. Different imaging modalities have been used to clarify diagnosis and clinical relevance of these complications. Treatment options may range from wait-and-watch to emergency surgical interventions.
Indexed as
Identifiers
42159694What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.